Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 787 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Edgewise Therapeutics, Inc.
Market Cap
$4.27B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$4.15B
Net Profit Margin
12.82%
TTM Avg
-6.21%
3Y Avg
-4.84%
5Y Avg
-11.63%
Market Cap
$4.40B
Net Profit Margin
26.65%
TTM Avg
8.56%
3Y Avg
0.11%
5Y Avg
0.58%
Market Cap
$4.44B
Net Profit Margin
-20.73%
TTM Avg
-55.30%
3Y Avg
-87.73%
5Y Avg
-105.64%
Market Cap
$4.42B
Net Profit Margin
-55.82%
TTM Avg
-71.50%
3Y Avg
-84.24%
5Y Avg
-84.24%
Market Cap
$4.05B
Net Profit Margin
-248.83%
TTM Avg
-379.86%
3Y Avg
-278.01%
5Y Avg
-170.03%
Market Cap
$4.00B
Net Profit Margin
-2763.64%
TTM Avg
-2587.65%
3Y Avg
-6887.52%
5Y Avg
-6604.41%
Market Cap
$3.96B
Net Profit Margin
1.39%
TTM Avg
-2.46%
3Y Avg
-2.37%
5Y Avg
0.86%
Market Cap
$4.68B
Net Profit Margin
8.43%
TTM Avg
-12.40%
3Y Avg
-46.69%
5Y Avg
-46.69%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Edgewise Therapeutics, Inc. (EWTX) | $4.27B | 0.00% | 0.00% | 0.00% | 0.00% |
| LivaNova PLC (LIVN)vs › | $4.15B | 12.82% | -6.21% | -4.84% | -11.63% |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.40B | 26.65% | 8.56% | 0.11% | 0.58% |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.44B | -20.73% | -55.30% | -87.73% | -105.64% |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.42B | -55.82% | -71.50% | -84.24% | -84.24% |
| AbCellera Biologics Inc. (ABCL)vs › | $4.05B | -248.83% | -379.86% | -278.01% | -170.03% |
| Relay Therapeutics, Inc. (RLAY)vs › | $4.00B | -2763.64% | -2587.65% | -6887.52% | -6604.41% |
| ICU Medical, Inc. (ICUI)vs › | $3.96B | 1.39% | -2.46% | -2.37% | 0.86% |
| BillionToOne, Inc. (BLLN)vs › | $4.68B | 8.43% | -12.40% | -46.69% | -46.69% |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.65B | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
